South Texas Oncology and Hematology

San Antonio, Texas 78258

1 studies enrolling now · 17 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Cancer of the Rectum, Carcinoma of Unknown Primary, Chronic Myeloproliferative Disorders, Colorectal Cancer, Glioblastoma Multiforme, Infection, Leukemia, Lymphoma, Malignancies, Melanoma

Studies at this site

• A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment — Enrolling by invitation
• A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers — Running, not enrolling
• Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers — Completed
• Vinflunine in Hormone Refractory Prostate Cancer (HRPC) — Completed
• 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer — Completed
• RAD001 Plus Bevacizumab in Metastatic Melanoma — Completed
• Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer — Completed
• A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer — Completed
• A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer — Completed
• Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme — Completed
• Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary — Completed
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer — Completed
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site — Completed
• Pancreatic Cancer Serum and DNA Repository — Completed
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer — Completed
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma — Completed
• PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma — Completed